SUBSCRIBE
SUBSCRIBE

Gilead Sciences, Inc.

NEWS
Biotech Bay
Gilead Sciences, Inc.'s $1,000-A-Pill Hepatitis C Drug May Make Financial Sense For Prisons
October 21, 2014
 · 
1 min read
Job Trends
Gilead Sciences, Inc. To Create More Than 80 Jobs With $50 Million Expansion
October 21, 2014
 · 
2 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Policy
UBS: Gilead Sciences, Inc. Remains Solid Buy Despite Irish Tax Changes, Price War
October 15, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Business
Gilead Sciences, Inc. Nervous As Johnson & Johnson Looks To Remain Competitive In Hepatitis C Market
October 15, 2014
 · 
2 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Beach
Analysts: Harvoni News Nothing But Upside For Gilead Sciences, Inc.
October 13, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
FDA
FDA Approves Gilead’s New Hepatitis C Drug Harvoni
October 10, 2014
 · 
2 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Beach
Gilead Sciences, Inc. Will Have Higher Revenues, EPS On Liver Drug Strength: Citi
October 9, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Biotech Bay
Gilead Sciences, Inc.'s Solvadi May Be Barred From UK’s Service Plan
October 8, 2014
 · 
2 min read
Biotech Bay
University of California, Berkeley (CAL)'s Football Moves Forces Gilead Sciences, Inc. To Open Its Wallet
October 6, 2014
 · 
1 min read
Load More
  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Business
CURx Pharmaceuticals Snags Rights To Gilead Sciences, Inc.'s Lung Infection Drug
February 19, 2014
 · 
3 min read
Pharm Country
AHF: Gilead Sciences, Inc.’s $1,000 Hepatitis C Pill Target Of SF, NYC Protests Feb.12th
February 12, 2014
 · 
1 min read
Drug Development
Actelion Ltd.'s Lung Drug May Face Study Against Gilead Sciences, Inc. Rival
February 12, 2014
 · 
1 min read
Pharm Country
Gilead Sciences, Inc. COO: Analysts’ Sky-High Hep C Drug View “Not Unreasonable”
February 12, 2014
 · 
1 min read
Biotech Bay
Gilead Sciences, Inc. To Present At Two Upcoming Investor Conferences
February 11, 2014
 · 
1 min read
Policy
Gilead Sciences, Inc. Seeks FDA OK Of Oral Attack On Hepatitis C
February 11, 2014
 · 
3 min read
Business
Ex-Gilead Sciences, Inc. Exec Takes Job At Alexion Pharmaceuticals Inc. In Ireland
February 10, 2014
 · 
1 min read
Business
Gilead Sciences, Inc. To License Hepatitis C Drug To Lower-Cost Manufacturers In India
February 6, 2014
 · 
1 min read
Business
Gilead Sciences, Inc. On A Roll Even Before Breakthrough Hepatitis C Drug’s Effects
February 5, 2014
 · 
1 min read
Pharm Country
Mylan Inc. Named As Gilead Sciences, Inc.'s Exclusive Branded Medicines Business Partner For India
January 31, 2014
 · 
5 min read
Load More